Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

199
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
199
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

683
The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
683
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

22
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
22
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

70
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
70
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

18
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
18

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association of 340B entity eligibility with changes in hospital financial performance.

Health affairs scholar·2026
Same author

Principles and practices for successful gene therapy innovative contracting: Insights from a multistakeholder convening.

Journal of managed care & specialty pharmacy·2026
Same author

Cost-effectiveness thresholds used in the United States vs most favored nations.

Health affairs scholar·2026
Same author

The timeliness of health plan drug coverage policy changes to FDA label revisions.

Health affairs scholar·2026
Same author

Communication of launch prices by drug companies, 2022-2024.

The American journal of managed care·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Development and Validation of a Brief Healthcare Insecurity Scale in a Sample of U.S. Adults Living with and without HIV.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

A Competency Framework for Health Technology Assessment Expertise: Results from a Delphi Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Physician-led Switching from Reference Biologics to Biosimilars: What is the Effect on selected Health-Related Outcomes and Costs for IBD Patients in Germany?

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Critical Comments by the European Medicines Agency on Patient-Reported Outcomes in Regulatory Submissions (2020-2023).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Development, use and psychometric properties of vision and hearing bolt-ons for EQ-5D-3L and EQ-5D-5L: a systematic review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Developing Best Practice for Analysing Individual Patient Utility Data in Health Technology Assessment: A Modified Delphi Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
查看所有相关文章

相关实验视频

Updated: May 13, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

5.9K

在成本效益分析中确定有影响力的动态输入.

Melanie D Whittington1, Joshua T Cohen1, Peter J Neumann1

  • 1Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
|April 14, 2025
PubMed
概括
此摘要是机器生成的。

与静态方法相比,动态定价模型显著改变了成本效益估计,特别是对于长期治疗. 独家后的药物定价对于慢性护理的成本效益分析至关重要.

关键词:
分析成本效益分析.卫生技术评估 卫生技术评估价值评估评估的价值评估是如何进行的

更多相关视频

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
08:24

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies

Published on: August 25, 2023

577
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

相关实验视频

Last Updated: May 13, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

5.9K
The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
08:24

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies

Published on: August 25, 2023

577
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

科学领域:

  • 卫生经济学 卫生经济学
  • 药物经济学 药物经济学
  • 临床试验分析

背景情况:

  • 传统的成本效益分析 (CEA) 通常使用静态定价,这可能不准确地反映现实世界的经济动态.
  • 随着时间的推移,药品定价的变化,特别是专属权丧失后的变化,可能会对治疗的感知价值产生重大影响.
  • 了解动态输入的影响对于准确的医疗保健资源分配至关重要.

研究的目的:

  • 为了比较来自静态与动态定价模型的成本效益估计.
  • 确定哪些动态输入因素最显著地影响了成本效益的结果.
  • 通过不同的治疗方案 (慢性与灾难性疾病,长期与一次性治疗) 评估这些方法.

主要方法:

  • 经济建模专家召开会议,确定动态成本效益分析输入和建模方法.
  • 静态和动态的成本效益估计计算了四个不同的案例研究.
  • 该研究分析了包括慢性和灾难性疾病在内的情景,以及一次或长时间的治疗.

主要成果:

  • 在所有情况下,动态成本效益估计总是比静态估计更有利.
  • 这种差异从82% (慢性治疗,慢性疾病) 到27% (一次性治疗,灾难性疾病) 之间.
  • 对于长期治疗,失去独家权后的定价是最有影响力的动态因素;对于一次性治疗,基线年龄和折扣率比价格变化更具影响力.

结论:

  • 与静态方法相比,动态建模方法的成本效益估计大大不同,往往更有利,特别是对于持续时间长的治疗方法.
  • 准确估计价格变化,特别是在失去市场独家权后,是未来制药经济学研究的关键领域.
  • 动态建模提高了医疗保健决策成本效益评估的精度.